What was filed
Deepak Nitrite's Board met on 4 August 2026 and approved the unaudited standalone and consolidated results for the quarter ended 30 June 2026, filed under Regulation 33 of the SEBI Listing Regulations. Statutory auditor Deloitte Haskins & Sells LLP issued a limited review report on both sets, noting nothing that caused it to believe the statements contained a material misstatement.
How the quarter looked
On a consolidated basis, both revenue and profit rose year-on-year against the June 2025 quarter, with the improvement concentrated in Phenolics, whose result before tax and interest more than tripled versus a year earlier per the segment disclosure. The Advanced Intermediates segment also posted a higher result. Standalone revenue and profit likewise improved. Consolidated finance costs were higher than a year ago, per the filing.
Notes worth flagging
Consolidated revenue includes government incentive income of ₹21.50 crore recognised in one subsidiary for the June 2026 quarter, per Note 3. The results consolidate eight entities, including Deepak Phenolics Limited and overseas units. The company also noted a prior provision of ₹10.51 crore (standalone) and ₹12.84 crore (consolidated) taken as an exceptional item in the year ended March 2026 relating to the New Labour Codes; the June 2026 quarter carries no such exceptional item.